E. coli Secretion Technologies Enable Production of High Yields of Active Human Antibody Fragments - Technical

Feedback Advertise Submit Papers Reprints About Help Contact

Advanced Search

Follow BPI on Twitter

Upstream Processing Downstream Processing Manufacturing Analytical Facilities

Archive by Issue Archive by Article Type Supplements

CMC Forum Press Releases

Technical

E. coli Secretion Technologies Enable Production of High Yields of Active Human Antibody Fragments

Merlind Mücke, Ralf Ostendorp, and Susanne Leonhartsberger

Full Text (PDF)

Print this page | Send to a colleague| Email the Editor

Biopharmaceutical Production
Facility Design Strategies for Single-Use Technologies

Please join us for a free webinar addressing strategies for facility design in biopharmaceutical manufacturing:

Wednesday, 29 February 2012
8:00 AM and 1:00 PM EST

Presented by:

Ingrid Long, MSc
Research Engineer
GE Healthcare Life Sciences

During the webinar, Ms. Long will discuss the impact of different strategies for facility design, with a focus on the following topics:

* Replacement of traditional equipment with the single-use equivalent
* Biopharmaceutical manufacturing in a single room
* Benefits of facility design with respect to cost, risk, and flexibility

Editors' Blog

Biopharmaceutical Development and Production Week

Nine Conferences — One Location: Hilton Bayfront (San Diego, CA)

Current Issue